ISN Academy. Hao C.
Apr 24, 2019; 272229
Topic: Chronic kidney disease
Chuan-Ming Hao
Chuan-Ming Hao
Login now to access Regular content available to all registered users.

You may also access ISN content "anytime, anywhere" with the FREE ISN Academy App for iOS and Android.
Learning Objectives
Discussion Forum (0)
Rate & Comment (0)
This proposed symposium will provide current information about the clinical significance of both anemia and hyperkalemia in patients with chronic kidney disease (CKD). Numbers of prevalent CKD patients have increased and will continue to rise; thus, practitioners will be confronted with management of these complex medical problems unique to patients with chronic renal impairment. Data suggests there are gaps in optimally managing both anemia and hyperkalemia. Fortunately, new insights into the pathophysiology of both complications have yielded novel treatment targets that may optimize patient management. This educational program will provide expert insights into emerging therapies for management of anemia and hyperkalemia of CKD. The faculty panel will explore all the latest clinical trial data and discuss how these novel agents compare to other therapies used in clinical practice.
Expected Learning Outcomes:
Following are learning outcomes expected from the audience at the conclusion of this symposium.
  • Emphasis will be placed on these learning objectives and changes in practice. Examine the prevalence of and risk factors for hyperkalemia and its associated prognosis across healthcare settings
  • Appraise the recent shifts in treatment patterns that have occurred in the management of anemia in CKD
  • Describe commonly applied therapies for anemia and hyperkalemia and understand their advantages and disadvantages.
  • Become familiar with novel treatments for hyperkalemia and anemia, and their role in changing therapeutic paradigms optimizing management.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings